Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 - PROTHENA CORP PUBLIC LTD CO | prta201710-kxex311.htm |
| EX-32.1 - EXHIBIT 32.1 SECTION 906 CERTIFICATION - PROTHENA CORP PUBLIC LTD CO | prta201710-kxex321.htm |
| EX-31.2 - EXHIBIT 31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 - PROTHENA CORP PUBLIC LTD CO | prta201710-kxex312.htm |
| EX-21.1 - EXHIBIT 21.1 LIST OF SUBSIDIARIES - PROTHENA CORP PUBLIC LTD CO | prta201710-kex211listofsub.htm |
| 10-K - FORM 10-K - PROTHENA CORP PUBLIC LTD CO | prta201710-k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Prothena Corporation plc:
We consent to the incorporation by reference in the registration statements (Nos. 333-218184, 333-211653, 333-196572 and 333-187726) on Form S-8 and the registration statements (Nos. 333‑203258, 333-197006, 333-196965 and 333-193416) on Form S-3 of Prothena Corporation plc of our reports dated February 23, 2018 with respect to the consolidated balance sheets of Prothena Corporation plc as of December 31, 2017 and 2016, and the related consolidated statements of operations, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2017, and the related notes (collectively, the “consolidated financial statements”), and the effectiveness of internal control over financial reporting as of December 31, 2017, which reports appear in the December 31, 2017 annual report on Form 10‑K of Prothena Corporation plc.
/s/ KPMG LLP
San Francisco, California
February 23, 2018